Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation

Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation

We will study 40 matched patients. 20 patients will receive leukoreduced whole blood from the solid organ donor. These 20 patients will be compared to 20 historical matched controls with regards to allogenic blood product usage and other physiologic markers

Inclusion Criteria:

• - Recipients 18 years or older.
• Deceased donor whole graft liver transplant recipients undergoing liver transplant starting 07/01/2020 and onwards at VUMC.
• ABO-matched recipient and donor.
• Donor Hb level >/= 8 g/dL
• Recipients with negative ABO antibody screen

Exclusion Criteria:

• - Pediatric recipient.
• HBS Antigen+ donors
• HCV NAT+ donors
• Donors of A2 blood type
• Donors on oral anticoagulants (except for aspirin) over the past 3 days before organ procurement